Spark Therapeutics officially broke ground Tuesday on its $575 million Gene Therapy Innovation Center in University City — a project that will double the company’s physical footprint in Philadelphia. The more than 500,000-square-foot, six-story building at 30th and Chestnut streets on Drexel University’s campus is being designed to serve as the global gene therapy manufacturing… Read more »
One of Philadelphia’s leading gene therapy companies is setting out to build what could be by far the most prominent biomanufacturing facility in the city to date. Spark Therapeutics will build a $575M gene therapy manufacturing facility on what is now a parking lot owned by Drexel University at 30th and Chestnut streets, the company announced Friday. Spark has agreed to… Read more »
